Pharmaceutical

UK point-of-care production of cell therapies could arrive in 2025

The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.

Nov 23, 2024 - 06:00
UK point-of-care production of cell therapies could arrive in 2025
The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
Read the original article

Tags:

Previous Article

Incyte’s $750M Acquisition Shaken by Key Trial Pause and Asset Cuts

Next Article

J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Can supermarket pharmacies plug urgent healthcare gaps?

Can supermarket pharmacies plug urgent healthcare gaps?

Jun 18, 2024

STAT+: The ADC hot streak continues: J&J to buy cancer drug developer Ambrx Biopharma

STAT+: The ADC hot streak continues: J&J to buy cancer ...

Jan 8, 2024

Ablaze Pharmaceuticals to develop drug candidate for liver cancer

Ablaze Pharmaceuticals to develop drug candidate for li...

Apr 3, 2023